Byron King: Companies Must Pay Dividends to Make Top-10 Gold List
Source: Brian Sylvester of The Gold Report  (6/8/12)
The world still needs gold and other natural resources, but we may need a new investment model to sustain them, says Byron King, writer and editor for Agora Financial's Outstanding Investments and Energy & Scarcity Investor newsletters and contributor to the Daily Resource Hunter. Despite ongoing market volatility, he names several midtier and small-cap gold equities for investors with a "reasonable" tolerance for risk. In this exclusive Gold Report interview, King also shares his perspective on the practical and political future of gold mining in South Africa. More >

Gold Falls Following 'Bernanke Curve Ball'
Source: Ben Traynor, BullionVault  (6/8/12)
"'Gold bulls were very disappointed by Bernanke's testimony yesterday,' says Lynette Tan, investment analyst at Phillip Futures in Singapore." More >

India a Major Force in Gold Outlook
Source: The Street  (6/8/12)
"The value of the Indian rupee has fallen so much against the dollar that gold is now making new highs in India." More >

Gold Bullion to Go: A New Way to Buy Physical Gold
Source: Forbes, Abram Brown  (6/8/12)
"GBI is essentially an exchange for gold, silver, platinum and palladium. It says it wants to hack away at the hefty premium investors often pay above spot prices. This can amount to between 5% and 10% for gold." More >

Continued Volatility Expected in Gold Price
Source: Investment Europe, Sharps Pixley  (6/8/12)
"Monetary and political policies are the key drivers of volatility in the near-term gold price." More >

Strong-Dollar Fallacy
Source: Adam Hamilton, Zeal Intelligence  (6/8/12)
"No commodity is more responsive to the U.S. dollar's fortunes than gold. The sharp dollar surge in May drove a full-blown capitulation in gold stocks and to a lesser extent in the metal itself. Capital is already returning after that rare selling-exhaustion event, laying the groundwork for a major new upleg." More >

IMF Eying Spain's Gold: Trader Rog
Source: Roger Wiegand, Trader Tracks  (6/8/12)
"Bernanke's plan will probably work for the shorter view, but his Achilles Heel, and he knows it, is a massive loss of confidence in the world's bond markets." More >

A Star Is Born at ASCO 2012
Source: Medical Technology Stock Newsletter  (6/8/12)
"This year's ASCO winners appear to have solid momentum that is allowing them to buck the 'sell ASCO' mantra." More >

Reap Biotech Profits from Overlooked Spaces: Alan Carr
Source: George S. Mack, The Life Sciences Report  (6/7/12)
Within the investment community, the story goes that new antibiotics can't generate big profits and central nervous system (CNS) drugs are too difficult to develop. Investors worry they could be throwing good money after bad. Senior Biotechnology Analyst Alan Carr of Needham & Company refutes these tales and believes that product differentiation provides the formula for success. In this exclusive interview with
The Life Sciences Report,
Carr shares his deep industry knowledge and renders his very best ideas in the CNS, antibiotic, antiviral and metabolic spaces. More >

A Major Uranium Supply Gap Is Looming: Ed Sterck
Source: Padma Nagappan of The Energy Report   (6/7/12)
With Japan set to restart reactors and Russia's Megatons to Megawatts program near its expiration date, Analyst Edward Sterck thinks uranium stocks could pick up momentum, even if uranium prices show no inclination of heading north. In this exclusive interview with The Energy Report, Sterck warns of a supply-demand gap that could hit the world as early as 2015. In the meantime, consolidation is the name of the game. More >

The Best Oil ETFs for Any Move in Crude
Source: Larry D. Spears, Money Morning  (6/7/12)
"Oil price estimates range from a fairly conservative average of $104/bbl, as forecast by the EIA, to a turmoil-driven $200/bbl. Either one represents a substantial profit opportunity for energy bulls." More >

Gold and Silver Update: Looking Ahead
Source: Peter Degraaf  (6/7/12)
"Fundamentals are supporting the current bull market in the metals, as central banks are adding to the money supply at double-digit rates. The technical indicators, along with seasonal indicators, are pointing to a resumption of the bull market." More >

Is the Table Set for a Mania in Precious Metals?
Source: Jeff Clark, Casey Research  (6/7/12)
"A mania in gold and gold stocks is the likely result of the absolute balloon in government debt, deficit spending and money printing." More >

Gold's Second-Half Performance Dependent on QE
Source: Bob Kirtley, SK Options Trading  (6/7/12)
"We expect politicians and central bankers to turn to quantitative easing as their 'get out of jail' card and this will propel gold to the $2,000/oz level before the end of the year." More >

House Votes to Repeal Medical Device Tax
Source: Washington Post, Ed O'Keefe  (6/7/12)
"The Health Care Cost Reduction Act of 2012 would repeal a 2.3% excise tax on gross sales receipts in excess of $5M for manufacturers and importers of certain medical devices, including defibrillators, pacemakers and prosthetic limbs. Congressional budget officials estimate that the tax would raise nearly $30B in revenue between 2013 and 2022." More >

The End of Cheap Everything: Ron Hera
Source: Brian Sylvester of The Gold Report   (6/6/12)
For his money—and the portfolio he offers investors is also his own—Ron Hera, founder of Hera Research, wants uniquely good companies. In an exclusive interview with The Gold Report, Hera shares why he is bullish on gold, finds silver volatile but worth investment and encourages new investors to dig a little to find hidden possibilities. More >

Bear Channel Broken for Gold
Source: Ben Traynor, BullionVault  (6/6/12)
"U.S. dollar gold prices climbed to a one-month high at $1,640/oz ahead of Wednesday's U.S. session, a gain of more than 7% from May's low, while stocks, commodities and the euro also ticked higher and major government bond prices fell." More >

Adrian Day: Gold Liquidation Phase Winding Down
Source: Kitco, Allen Sykora  (6/6/12)
"Money Manager Adrian Day figures the liquidation phase in gold has about run its course and the metal may be about to get a boost from looser monetary policies around the world." More >

Gold Bugs Defy Bear-Market Threat with Soros Buying
Source: Bloomberg, Nicholas Larkin and Debarati Roy  (6/6/12)
"Billionaire George Soros bought more in the first quarter and hedge-fund manager John Paulson held on to the biggest stake in the SPDR Gold Trust, the largest exchange-traded product backed by bullion, Securities and Exchange Commission filings show." More >

New Technique Offers Better Understanding of Human Tissues
Source: ScienceDaily   (6/6/12)
"The study is one of the first to explore how this technology, called bimodal dual AC mode microscopy, can improve our understanding of human tissues and biomaterials." More >

New AMA Chief: No Chaos with Court's Health Ruling
Source: Associated Press, Lindsey Tanner  (6/6/12)
"The AMA has supported Obama's health overhaul, though a vocal contingent of doctor-members has urged the group to back off that stance." More >

On Jelly Donuts and Gold
Source: Eric Fry, The Daily Reckoning  (6/6/12)
"Gold is not merely a great thing to own amidst extreme circumstances. It can also be a great thing to own amidst merely marginal circumstances, for example, if you happen to be living during the tail end of one of the most powerful, world-dominating economic expansions in human history. . .rather than at the beginning of it." More >

Gold Standard, Gold Futures and Perception Management
Source: James West, The Midas Letter  (6/6/12)
"Gold is the buy for the long term. Gut-wrenching plunges in the price should be expected and ignored, except perhaps to buy more on such dips." More >

Gold: A Modest Proposal
Source: Paul Tustain, BullionVault  (6/6/12)
"For the time being, London remains the world center for professional bullion trading, thanks to its time-zone advantage and its unique infrastructure and expertise. Gold bullion turnover in the London market averages more than $240B per day." More >

Six Biotech Stocks Riding the Baby Boomer Wave
Source: Diane Alter, Money Morning  (6/6/12)
"While no one has discovered a cure for Alzheimer's, cancer, Parkinson's or other ailments that come along with old age, several biotech companies are racing to cure a long list of diseases and disorders. The prospects are daunting but the possibilities in the biotech field are literally endless, for patients and investors alike." More >